Insider Flush: Aehr Test Systems EVP Sells 204 Shares at $93.07 Just as Stock Skirts 52‑Week High—What It Means for Investors

Insider Selling at Aehr Test Systems: What the Numbers Say

The most recent Form 4 filed on May 1, 2026 shows that EVP Alberto Salamone sold 204 shares of Aehr Test Systems common stock at $93.07 per share—just $0.03 above the day‑trading close of $90.56. The sale was a routine “sell” transaction that reduced Salamone’s holdings to 47,821 shares. While the amount of shares sold is modest compared with his historical activity, the timing and frequency of his transactions raise questions about his outlook on the company’s near‑term performance.

Patterns of Insider Activity

Alberto Salamone has been a prolific seller in the last few months. From early April through the first week of May, he executed four sizable sales—15 000 shares on April 20, 15 000 on April 21, 553 on April 2, and 234 on February 1—reducing his stake from 78,025 shares to 47,821. These transactions were all at prices ranging from $6.67 to $94.56, a broad spread that mirrors the company’s volatility over the quarter. Notably, his most recent sale on May 1 occurred when the stock was trading near its 52‑week high of $102.48, suggesting a short‑term profit‑taking move rather than a long‑term divestiture.

When viewed against the backdrop of other insiders’ behavior—such as CEO Erickson Gayn’s series of sell orders in late April and director Scott Gates’ charitable transfer—Salamone’s actions appear consistent with a pattern of opportunistic liquidity. The overall insider selling volume in the past month exceeded 300 000 shares, a level that could weigh on sentiment if investors interpret it as a lack of confidence in the company’s trajectory.

Implications for Investors

For equity holders, the concentrated insider selling signals a potential re‑evaluation of Aehr’s valuation. The stock’s year‑to‑date gain of 1,026 % and a P/E ratio of –214.14 indicate that the market still prizes the company’s growth prospects, yet the recent 2.96 % weekly decline and a 135 % monthly rise reflect heightened volatility. If insiders continue to trim positions, it could accelerate a price correction, especially if combined with external market pressure or negative earnings guidance.

Conversely, the modest size of each sale relative to the company’s 2.57 billion‑share market cap and the fact that Salamone remains a significant shareholder (over 47 000 shares) suggest that he is not abandoning the business outright. His pattern of selling during market highs may reflect a desire to lock in gains while maintaining a long‑term stake. For investors with a medium‑term horizon, the insider activity could be viewed as a short‑term signal rather than a definitive warning.

Who is Alberto Salamone?

Alberto Salamone, EVP of Product and Business Development, has been active in Aehr’s insider trading for several months. His transactions span a range of prices that mirror the company’s market swings, from as low as $6.67 in early April to as high as $94.56 in late April. Historically, Salamone’s sales have been concentrated in the 10,000–15,000 share range, suggesting he trades in sizeable blocks. The most recent sale on May 1 appears consistent with his trend of liquidating shares when the price approaches a recent high. While his holdings still constitute a meaningful portion of the total outstanding shares, his activity has not shown a clear shift toward accumulation, pointing to a pragmatic approach to portfolio management rather than a bullish or bearish stance.

Takeaway

Insider selling at Aehr Test Systems, led by EVP Alberto Salamone, is a regular feature of the company’s trading activity. The recent May 1 sale aligns with Salamone’s pattern of profiting from market peaks while retaining a long‑term position. For investors, the key will be monitoring whether insider selling intensifies and how it aligns with Aehr’s earnings trajectory and broader semiconductor market dynamics. A cautious approach—recognizing the potential for short‑term volatility but not necessarily a fundamental shift—may be prudent as the company continues to navigate a highly cyclical industry.